Wellington Management Group
AEGR

Wellington Management Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

Wellington Management Group’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-18,500
Closed -$618K – 2304
2014
Q3 		$618K Buy
+18,500
New +$574K ﹤0.01% 1937
2013
Q3 		– Sell
-208,756
Closed -$13.2M – 2271
2013
Q2 		$13.2M Buy
+208,756
New +$11.1M ﹤0.01% 1100

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group's AEGR Position: Q4 2014 in Review

Wellington Management Group sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2014, closing a stake of 18,500 shares — an estimated $618K sold.

Wellington Management Group first reported a position in AEGR in Q2 2013 and held it in 2 quarters. The position peaked at $13.2M in Q2 2013. 95 funds tracked by Wall St. Rank hold AEGR as of Q4 2014.

  • Wellington Management Group reported no remaining Aegerion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Wellington Management Group sold 18,500 Aegerion Pharmaceuticals shares in Q4 2014, an estimated $618K.
  • Wellington Management Group first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 2 quarters.
  • Wellington Management Group's Aegerion Pharmaceuticals position peaked at $13.2M in Q2 2013.
  • 95 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2014.

Based on Wellington Management Group's 13F filing for Q4 2014, filed 13 Feb 2015.